This phase II trial gathers information on the feasibility, safety, and effect of giving methotrexate, erlotinib, and celecoxib in treating head and neck cance…

Metastatic Oral Cavity CarcinomaRecurrent Oral Cavity CarcinomaStage IVC Lip and Oral Cavity Cancer AJCC v8+15 more

~Estimated

~$10 – $6,250

Mayo ClinicNCT06997068

Observational

G-FORCE: Phase II Randomized Study of Glottic Larynx Hypofractionated Radiotherapy Versus ConvEntional Radiotherapy

To compare the acute tolerance of highly conformal hypofractionated versus conventional radiotherapy.

Laryngeal Carcinoma

~Estimated

~$10 – $6,250

University of Texas Southwestern Medical CenterNCT06080503